What happened
132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer
SourceElsevier BVpublicationBiotech
132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer
Publication signal: 132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceElsevier BVLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceElsevier BVLinked output
132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancerpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Diagnostics and Biomarkers
Controlled AISci Stage A topic for Diagnostics and Biomarkers.
132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer
132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer
Timeline
- publication132P Precision medicine and systems biology analysis for the identification of PI3K pathway biomarkers and therapeutic candidates in ovarian cancer